[EN] HETEROCYCLIC COMPOUNDS USEFUL AS MODULATORS OF TNF ALPHA<br/>[FR] COMPOSÉS HÉTÉROCYCLIQUES UTILES EN TANT QUE MODULATEURS DU TNF ALPHA
申请人:BRISTOL MYERS SQUIBB CO
公开号:WO2017023905A1
公开(公告)日:2017-02-09
Disclosed are compounds of Formula (I) or a salt thereof, wherein: A is CR1 or N; B is CR3 or N; D is CR4 or N; L1 is -(CR7R7)m-; L2 is -(CR7R7)n-; and X, Z, R1, R2, R3, R4, R5,and R6 are define herein. Also disclosed are methods of using such compounds as modulators of TNFα, and pharmaceutical compositions comprising such compounds. These compounds are useful in treating inflammatory and autoimmune diseases.
披露了公式(I)化合物或其盐,其中:A是CR1或N;B是CR3或N;D是CR4或N;L1是-(CR7R7)m-;L2是-(CR7R7)n-;X,Z,R1,R2,R3,R4,R5和R6都在此定义。还披露了将此类化合物用作调节TNFα的调节剂的方法,以及包含此类化合物的药物组合物。这些化合物可用于治疗炎症和自身免疫性疾病。